22-09-2026 17:17 via drugs.com

MHT Initiation May Reduce Cardiovascular Risk in Women With Vasomotor Symptoms

TUESDAY, Sept. 22, 2026-- Menopausal hormone therapy (MHT) initiation in perimenopausal or recently postmenopausal women with vasomotor symptoms may reduce cardiovascular disease (CVD) risk, with more pronounced benefits in women who initiated MHT...

High Intake of Eggs, Peanuts in Pregnancy Does Not Lower Allergy Risk

Gene Mutation Identified That Increases Lung Cancer Risk

What Happens When You Can’t See A Family Doctor Regularly?

Surveillance Colonoscopy at Five Years After Adenoma Removal Noninferior to Three Years

Mammography Trials Yield Excess-Incidence Patterns Consistent With Low Overdiagnosis

Blinatumomab Improves Event-Free Survival in Children With High-Risk B-Cell ALL

Cirrhosis Can Recur After Liver Transplant

Kratom Cases Climb Sharply Across The US

Mortality Lowest at Hemoglobin Concentrations Above WHO Thresholds

Rheumatic Immune-Related AEs With Immune Checkpoint Inhibitors More Severe Than Previously Reported

Cardiovascular Health And Exercise: How Much Aerobic Activity Do You Really Need?

Mindfulness, Tai Chi Can Ease Pain, Fatigue Among Cancer Survivors

Interest In Dementia Vaccine High In U.S., Survey Finds

Marathons Safe For People With Type 1 Diabetes, Study Says

Desktop versie

MHT Initiation May Reduce Cardiovascular Risk in Women With Vasomotor Symptoms

Pharmaceutical news